These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Conjugated estrogens: do not substitute. Ansbacher R Am Pharm; 1990 Jul; NS30(7):27-8. PubMed ID: 2163583 [No Abstract] [Full Text] [Related]
6. Conjugated estrogens: FDA's position. Burlington DB Am Pharm; 1990 Jul; NS30(7):28-9. PubMed ID: 2163584 [No Abstract] [Full Text] [Related]
7. [Generic drugs, bioavailability, and bioequivalence]. Palma-Aguirre JA Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395 [No Abstract] [Full Text] [Related]
8. Comments on the note for guidance on bioavailability and bioequivalence in the European Union. Calvo G Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721 [No Abstract] [Full Text] [Related]
9. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model. Walker SE; Friesen MH J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658 [TBL] [Abstract][Full Text] [Related]
10. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence]. Blume H Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214 [No Abstract] [Full Text] [Related]
11. [Bioequivalence of generic drugs: sense and nonsense]. Brune K; Dietzel K Fortschr Med; 1988 Nov; 106(33):16-7. PubMed ID: 3209169 [No Abstract] [Full Text] [Related]
12. Is bioavailability altered in generic versus brand anticonvulsants? Jankovic SM; Ignjatovic Ristic D Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299 [TBL] [Abstract][Full Text] [Related]
13. Types of bioequivalence and related statistical considerations. Hauck WW; Anderson S Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546 [TBL] [Abstract][Full Text] [Related]
14. [Bioequivalence of generic drugs]. Schwabe U Internist (Berl); 1988 Mar; 29(3):147-59. PubMed ID: 3288573 [No Abstract] [Full Text] [Related]
15. Evaluating the bioavailability and bioequivalence of generic medications. Howland RH J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women. Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623 [TBL] [Abstract][Full Text] [Related]
17. [Bioequivalence studies of pharmaceutical preparations]. Vetchý D; Frýbortová K; Rabisková M; Danecková H Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963 [TBL] [Abstract][Full Text] [Related]
18. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends. Srinivas NR Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891 [TBL] [Abstract][Full Text] [Related]